Home > Publications database > SRChing for new targets in HCC. > print

001     299484
005     20251117114901.0
024 7 _ |a 10.1097/HEP.0000000000001285
|2 doi
024 7 _ |a pmid:39999450
|2 pmid
024 7 _ |a 0270-9139
|2 ISSN
024 7 _ |a 1527-3350
|2 ISSN
037 _ _ |a DKFZ-2025-00444
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dill, Michael
|0 P:(DE-He78)54a6641a6c26ddc49cc754740e90b438
|b 0
|e First author
|u dkfz
245 _ _ |a SRChing for new targets in HCC.
260 _ _ |a [Alphen aan den Rijn]
|c 2025
|b Wolters Kluwer Health
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763376509_1699450
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D500# / 82(6):p 1408-1410, December 2025 / Leitartikel
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Tchorz, Jan S
|b 1
773 _ _ |a 10.1097/HEP.0000000000001285
|0 PERI:(DE-600)1472120-X
|n 6
|p 1408-1410
|t Hepatology
|v 82
|y 2025
|x 0270-9139
909 C O |p VDB
|o oai:inrepo02.dkfz.de:299484
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)54a6641a6c26ddc49cc754740e90b438
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-03
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-03
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-03
920 1 _ |0 I:(DE-He78)D500-20160331
|k D500
|l NWG Experimentelle Hepatologie, Entzündung und Krebs
|x 0
920 0 _ |0 I:(DE-He78)D500-20160331
|k D500
|l NWG Experimentelle Hepatologie, Entzündung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D500-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21